Concepedia

Robert Tjin Tham Sjin

RT

11

Publications

1.2K

Citations

11

H-Index

1994

Active since

Affiliations

Vanderbilt University(Current)

Harvard University

Clovis Oncology (United States)

University of Pennsylvania

Robert Tjin Tham Sjin is an author at Vanderbilt University specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

1994–2022

11

Publications

11

Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter, Robert Tjin Tham Sjin, Henry J. Haringsma et al. · Cancer Discovery · 2013 · 622 citations · Full text

The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells.

Muthu Selvakumaran, Hsueh‐Kung Lin, Robert Tjin Tham Sjin et al. · Molecular and Cellular Biology · 1994 · 185 citations · Full text

, , +16

<i>In Vitro</i> and <i>In Vivo</i> Characterization of Irreversible Mutant-Selective EGFR Inhibitors That Are Wild-Type Sparing

Robert Tjin Tham Sjin, Kwangho Lee, Annette O. Walter et al. · Molecular Cancer Therapeutics · 2014 · 70 citations

, , +14

VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma

Julie A. Shields, Samuel R. Meier, Madhavi Bandi et al. · Cancer Research · 2022 · 64 citations · Full text

Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts

Helen M. Nugent, Robert Tjin Tham Sjin, Desmond White et al. · Journal of Vascular Surgery · 2007 · 53 citations · Full text

, , +13

Rows per page

1–5 of 11